Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
Clinical trial NCT07040930 · RECRUITING
Trial details
- NCT number
- NCT07040930
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-07-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.